William Fenn
Foot & Ankle Surgery · Southborough, MANPI 1184897415
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Kairos Surgical Inc at 55.5% of the total. Reporting peaked in 2021 at $1,215 and has fallen 95.2% since, to $58 in 2024.
Across 27 payments — averaging $84.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$1K
- Stryker$319
- Misonix Inc$156
- Orthofix Medical, Inc.$145
- Smith+Nephew$122
- Kerecis Limited$120
- plus $148 from 4 others
What the payments were for
- Speaking & faculty fees$1386%
- Food & beverage$93141%
- Education$1,20053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 4 | $1,259 |
| Stryker(2 entities) | 10 | $319 |
| Misonix Inc | 4 | $156 |
| Orthofix Medical, Inc. | 3 | $145 |
| Smith+Nephew | 1 | $122 |
| Kerecis Limited | 1 | $120 |
| Medical Device Business Services, Inc. | 1 | $79 |
| Johnson & Johnson | 1 | $30 |
| Fortis Surgical, LLC | 1 | $25 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSkin$122
- Stravix$122
- Kerecis Omega3 Wound$120
- CARTIVA$107
How this compares
$2,269 in reported general payments places this provider in the 55th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 26 | $743 |
| Clotrimazole | 32 | $613 |
| CiclopiroxCiclopirox Olamine | 19 | $488 |
| Doxycycline Monohydrate | 14 | $154 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Southborough
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
- Jaeyoung KimBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.